DTC FDA Issues Enforcement Letter Regarding Eskata Risks Omitted From DTC… Thomas Sullivan Aug 2, 2019 0 The US Food and Drug Administration (“FDA”) Office of Prescription Drug Promotion (“OPDP”) recently issued an enforcement letter…
